Ignite Creation Date:
2024-05-06 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 2:27 PM
Study NCT ID:
NCT05276713
Status:
UNKNOWN
Last Update Posted:
2022-03-11
First Post:
2022-03-03
Brief Title:
Outcome of Tucidinostat-Based Therapy in HR Metastatic Breast Cancer Patients Previously Treated With CDK46 Inhibitor
Sponsor:
Organization:
Beijing 302 Hospital